DXCM Dexcom


Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

ESG term mentions

In last year of SEC filings
AirCircularCleanClimateContaminantCoralEnvironmentEnvironmentalForestLeachLife CycleLifecycleMaterialsMineralNatural ResourcesNatureOffsetPackagePackagingPandemicPlasticRaw MaterialsWasteAccessAffordabilityAfrican AmericanBenefitsBlackCalifornia Consumer Privacy ActCitizenshipCollective BargainingCommunityCultureCustomerCustomer SatisfactionCyberCybersecurityData PrivacyData SecurityDeathDemographicsDisabilityDiversityEmployeeEmployee EngagementEmployee Resource GroupEngagementFrontline WorkersGenderGeneral Data Protection RegulationHealth and SafetyHealth CareHealthcareHireHiringHuman CapitalHuman ResourcesIncidentInjuryLatinxMinorityOpioidPay EquityPay for PerformancePay ParityPerquisitesPrivacyProduct QualityRecallRecruitReimbursementRetentionRetirementSafetySatisfactionSkilledSkillsSocialStakeholderSupplierSupply ChainSupply Chain ManagementTalentTrainingUnionVolunteerWomenWorkersWorkforceWorkplace SafetyAction PlanAnti-corruptionAssessmentAssuranceAttorney GeneralAttorneys GeneralAuditBoard EvaluationBonusBriberyChronicClassifiedClassified BoardClawbackCommitmentConflict of InterestCorporate GovernanceCorporate PurposeCorporate Social ResponsibilityCorruptionDepartment ofEnterprise Risk ManagementESGEthicsExecutive CompensationExpertFraudGoalsGovernanceHedgingIncentiveIncentivizeIndependenceIndependentInnovateInnovationInnovativeInvestigationLawsuitLead Independent DirectorLeadershipLitigationLong-termMajorityMaterialityOverseeOversightPerquisitePlaintiffPledgingProcurementProxy AccessProxy ContestPurposeQuality StandardReputationReputationalResearch and DevelopmentResponsibilityResponsibleSelf-evaluationSingle TriggerSpecial MeetingStockholder OutreachStrategySustainabilitySustainableTargetsTaxTenureTransparencyVoting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
(a) DexCom, Inc. (“DexCom”) held its Annual Meeting of Stockholders (the “Annual Meeting”) on May 21, 2020. Proxies for the Annual Meeting were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended. At the close of business on the record date, there were 92,344,868 shares outstanding and entitled to vote and 82,868,501 shares were voted in person or by proxy on the matters described below.

(b) The matters described below were voted on at the Annual Meeting and the number of votes cast with respect to each matter was as indicated:

(1) Holders of DexCom’s common stock voted to elect three Class III directors, each to serve until the DexCom’s 2023 annual meeting of stockholders and until their successor has been elected and qualified, or until their earlier death, resignation or removal as follows:

NameFor (#)Against (#)Abstentions
Broker Non-
Richard A. Collins76,890,953349,63942,5355,585,374
Mark G. Foletta75,399,4981,843,80139,8285,585,374
Eric J. Topol, M.D.74,925,6452,329,88727,5955,585,374

(2) Holders of DexCom’s common stock voted to ratify the appointment of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2020:

Number of Shares
Shares Voted in Favor:81,480,281
Shares Voted Against:1,356,391
Shares Abstaining:31,829

(3) Holders of DexCom’s common stock voted to approve the non-binding advisory resolution on compensation paid to DexCom’s named executive officers, as disclosed pursuant to